Hydralazine-induced Lupoid syndrome. Biochemical and immunological studies.
D000328:Adult; D001706:Biopsy; D001799:Blood Sedimentation; D011232:Chemical Precipitation; D003165:Complement System Proteins; D004247:DNA; D005455:Fluorescent Antibody Technique; D006025:Glycosaminoglycans / Q000652:urine; D006801:Humans; D006830:Hydralazine / Q000009:adverse effects* / Q000627:therapeutic use; D006909:Hydroxyproline / Q000652:urine; D005779:Immunodiffusion; D007122:Immunoelectrophoresis; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D008180:Lupus Erythematosus, Systemic / Q000097:blood / Q000139:chemically induced* / Q000473:pathology / Q000652:urine; D008297:Male; D009504:Neutrophils; D012595:Scleroderma, Systemic / Q000097:blood / Q000188:drug therapy / Q000652:urine; D012867:Skin / Q000473:pathology
D006025:Glycosaminoglycans; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D006830:Hydralazine; D003165:Complement System Proteins; D004247:DNA; D006909:Hydroxyproline